Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Toronto
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

TLB:CN

2.2200 CAD 0.0100 0.45%

As of 15:56:20 ET on 01/30/2015.

Snapshot for TearLab Corp (TLB)

Open: 2.2100 Day's Range: 2.2000 - 2.2200 Volume: 710
Previous Close: 2.2300 52wk Range: 1.9200 - 9.0900 1-Yr Rtn: -69.88%

Stock Chart for TLB

No chart data available.
  • TLB:CN 2.2200
  • 1D
  • 1M
  • 1Y
2.2300
Interactive TLB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TLB

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPTSX -
Earnings Per Share (USD) (ttm) -0.6300
Est. EPS (USD) (12/2014) -0.6960
Est. PEG Ratio -
Market Cap (M CAD) 74.57
Shares Outstanding (M) 33.59
30 Day Average Volume 3,489
Price/Book (mrq) 1.9360
Price/Sale (ttm) 3.0943
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TLB

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TLB

TearLab Corp. is an in-vitro diagnostics company. The Company develops and commercializes lab-on-a-chip technologies that enable eye care practitioners to test for sensitive and specific biomarkers in tears at the point-of-care.

Elias VamvakasChairman/CEOJoseph Jensen "Seph"President/COO
William G DumencuCFO/TreasurerMichael S BergVP:Clinical & Regulatory Ops
More Company Profile & Key Executives for TLB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil